[1]
Umar Yousaf Raja and Ponnusamy Saravanan, “Dapagliflozin: the outcome of it use as add-on therapy in real-life clinical setting”, J Pak Med Assoc, vol. 71, no. 9, pp. 2214–2217, Jul. 2021.